Fed. Circ. Rebuffs Attack On Skelaxin Invalidity Ruling
A federal appeals court on Monday rejected King Pharmaceuticals Inc.'s challenge to a lower court's conclusion that two patents King asserted against Eon Labs Inc. in a lawsuit over the muscle...To view the full article, register now.
Already a subscriber? Click here to view full article